Phibro Animal Health (PAHC) Other Non Operating Income (2012 - 2026)
Phibro Animal Health's (PAHC) quarterly Other Non Operating Income came in at -$1.9 million in Q1 2026, down 134.53% year-on-year from $5.5 million in Q1 2025, and up 11.0% quarter-over-quarter from -$2.1 million in Q4 2025.
Phibro Animal Health (PAHC) Other Non Operating Income (2012 - 2026) Analysis & Trends
Phibro Animal Health's Other Non Operating Income history runs 15 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 134.53% year-over-year to -$1.9 million in Q1 2026; TTM through Mar 2026 was -$8.2 million, a 40.56% increase from a year earlier, with the FY2025 full-year figure at -$7.9 million, up 67.02% from the prior year.
- Other Non Operating Income grew to -$1.9 million in Q1 2026 per PAHC's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $10.6 million in Q1 2022 and bottomed at -$11.7 million in Q4 2024.
- The 5-year median for Other Non Operating Income is -$2.1 million (2025), against an average of -$2.2 million.
- Across the five-year window, Other Non Operating Income jumped 1712.01% in 2022 and tumbled 5118.12% in 2023, its largest moves.
- Year by year, Other Non Operating Income stood at $149000.0 in 2022, then tumbled by 5118.12% to -$7.5 million in 2023, then slumped by 56.47% to -$11.7 million in 2024, then surged by 81.67% to -$2.1 million in 2025, then increased by 11.0% to -$1.9 million in 2026.
- Per Business Quant, the three latest PAHC Other Non Operating Income figures stand at -$1.9 million (Q1 2026), -$2.1 million (Q4 2025), and -$2.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.91 Mn |
| Dec 31, 2025 | -2.15 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | 5.53 Mn |
| Dec 31, 2024 | -11.70 Mn |
| Sep 30, 2024 | -438,000.00 |
| Jun 30, 2024 | -7.27 Mn |
| Mar 31, 2024 | -2.43 Mn |
| Dec 31, 2023 | -7.48 Mn |
| Sep 30, 2023 | -6.69 Mn |
| Jun 30, 2023 | 2.17 Mn |
| Mar 31, 2023 | 422,000.00 |
| Dec 31, 2022 | 149,000.00 |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -7.41 Mn |
| Mar 31, 2022 | 10.56 Mn |
| Dec 31, 2021 | 4.19 Mn |
| Sep 30, 2021 | -2.13 Mn |
| Jun 30, 2021 | 890,000.00 |